GT Biopharma, Inc.

Q2 2025 13F Holders

Symbol
GTBP
CUSIP
36254L308
Type
Equity
Class
COM
Num filers
22
Total reported value, excl. options
$711 k
Manager Report Date Value ($000) Shares Option Type